Erasmus Poku

1.0k total citations
33 papers, 660 citations indexed

About

Erasmus Poku is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Erasmus Poku has authored 33 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Erasmus Poku's work include Radiopharmaceutical Chemistry and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and HER2/EGFR in Cancer Research (8 papers). Erasmus Poku is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and HER2/EGFR in Cancer Research (8 papers). Erasmus Poku collaborates with scholars based in United States, Australia and United Kingdom. Erasmus Poku's co-authors include John E. Shively, David Colcher, Junie Chea, James R. Bading, Andrew Raubitschek, Paul Frankel, Paul J. Yazaki, Mary Carroll, Joanne Mortimer and Russell C. Rockne and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Erasmus Poku

30 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erasmus Poku United States 14 419 302 156 107 97 33 660
Cornelius Cilliers United States 11 347 0.8× 475 1.6× 295 1.9× 91 0.9× 150 1.5× 17 762
Alexander H. Staudacher Australia 15 355 0.8× 443 1.5× 225 1.4× 75 0.7× 141 1.5× 33 780
Hitomi Sudo Japan 17 289 0.7× 235 0.8× 246 1.6× 51 0.5× 167 1.7× 56 766
Huiyun Zhao China 19 458 1.1× 263 0.9× 254 1.6× 151 1.4× 124 1.3× 38 894
Melissa Nelson United States 11 208 0.5× 197 0.7× 185 1.2× 50 0.5× 53 0.5× 21 516
Johannes Heemskerk Belgium 8 641 1.5× 369 1.2× 295 1.9× 73 0.7× 76 0.8× 12 849
Nhat Le United States 15 481 1.1× 189 0.6× 202 1.3× 66 0.6× 107 1.1× 27 709
Conrad Chan Canada 16 504 1.2× 261 0.9× 213 1.4× 82 0.8× 158 1.6× 32 772
Desirée L. Bos Netherlands 15 216 0.5× 149 0.5× 159 1.0× 138 1.3× 93 1.0× 33 573
Janik Puttemans Belgium 11 340 0.8× 157 0.5× 179 1.1× 48 0.4× 95 1.0× 17 504

Countries citing papers authored by Erasmus Poku

Since Specialization
Citations

This map shows the geographic impact of Erasmus Poku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erasmus Poku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erasmus Poku more than expected).

Fields of papers citing papers by Erasmus Poku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erasmus Poku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erasmus Poku. The network helps show where Erasmus Poku may publish in the future.

Co-authorship network of co-authors of Erasmus Poku

This figure shows the co-authorship network connecting the top 25 collaborators of Erasmus Poku. A scholar is included among the top collaborators of Erasmus Poku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erasmus Poku. Erasmus Poku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Teresa, Patty Wong, Susanta Hui, et al.. (2025). Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors. Cancers. 17(9). 1453–1453.
2.
Poku, Erasmus, et al.. (2025). Safety profile of lutetium-177 in patients with impaired renal function: A retrospective analysis of adverse events in mCRPC treatment.. Journal of Clinical Oncology. 43(5_suppl). 123–123. 1 indexed citations
3.
Yazaki, Paul J., Patty Wong, Teresa Hong, et al.. (2024). Comparison of IL‐2‐antibody to IL‐2‐Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumors. Cancer Medicine. 13(3). e6909–e6909. 5 indexed citations
4.
Yazaki, Paul J., Patty Wong, Teresa Hong, et al.. (2023). Generation of IL‐2‐Fc‐antibody conjugates by click chemistry. Biotechnology Journal. 18(9). e2300115–e2300115. 5 indexed citations
5.
Lwin, Thinzar M., Teresa Hong, Tove Olafsen, et al.. (2023). Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer. Molecular Imaging and Biology. 25(4). 727–734. 7 indexed citations
6.
Wong, Jeffrey Y.C., Vikram Adhikarla, Paul Frankel, et al.. (2022). First-In-Human Pilot PET Immunoimaging Study of 64 Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers. Cancer Biotherapy and Radiopharmaceuticals. 38(1). 26–37. 9 indexed citations
7.
8.
9.
Mortimer, Joanne, James R. Bading, Paul Frankel, et al.. (2021). Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study. Journal of Nuclear Medicine. 63(8). 1145–1148. 23 indexed citations
10.
Wong, Patty, Lin Li, Junie Chea, et al.. (2020). Antibody Targeted PET Imaging of 64Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors. Bioconjugate Chemistry. 31(3). 743–753. 18 indexed citations
11.
Li, Lin, Paul J. Yazaki, Junie Chea, et al.. (2020). Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer. Cancer Medicine. 9(13). 4756–4767. 15 indexed citations
12.
Li, Daneng, Rebecca S. Allen, James R. Bading, et al.. (2020). Preclinical PET Imaging of NTSR-1-Positive Tumors with 64 Cu- and 68 Ga-DOTA-Neurotensin Analogs and Therapy with an 225 Ac-DOTA-Neurotensin Analog. Cancer Biotherapy and Radiopharmaceuticals. 36(8). 651–661. 4 indexed citations
13.
Li, Lin, Paul J. Yazaki, Junie Chea, et al.. (2020). TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody. Journal of Nuclear Medicine. 62(1). 55–61. 21 indexed citations
14.
Mikhaylova, Ekaterina, Farouk Nouizi, Maciej Kujawski, et al.. (2019). Prototype Small-Animal PET-CT Imaging System for Image-Guided Radiation Therapy. IEEE Access. 7. 143207–143216. 9 indexed citations
15.
Li, Junfeng, Jeffrey Rawson, Junie Chea, et al.. (2019). Evaluation of [68Ga]DO3A-VS-Cys40-Exendin-4 as a PET Probe for Imaging Human Transplanted Islets in the Liver. Scientific Reports. 9(1). 5705–5705. 17 indexed citations
16.
Mortimer, Joanne, James R. Bading, Jinha Park, et al.. (2017). Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer. Journal of Nuclear Medicine. 59(1). 38–43. 69 indexed citations
17.
Li, Lin, Junie Chea, Erasmus Poku, et al.. (2017). Diagnostic PET Imaging of Mammary Microcalcifications Using 64Cu-DOTA-Alendronate in a Rat Model of Breast Cancer. Journal of Nuclear Medicine. 58(9). 1373–1379. 11 indexed citations
18.
Wong, Patty, Lin Li, Junie Chea, et al.. (2017). Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model. Cancer Biotherapy and Radiopharmaceuticals. 32(7). 247–257. 13 indexed citations
19.
Yazaki, Paul J., Divya Channappa, Chi Wai Cheung, et al.. (2012). A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance. Protein Engineering Design and Selection. 26(3). 187–193. 29 indexed citations
20.
Li, Lin, Fabio Turatti, Desiree Crow, et al.. (2010). Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved64Cu PET. Journal of Nuclear Medicine. 51(7). 1139–1146. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelius Cilliers Breakdown of academic impact, for papers by Alexander H. Staudacher Breakdown of academic impact, for papers by Hitomi Sudo Breakdown of academic impact, for papers by Huiyun Zhao Breakdown of academic impact, for papers by Melissa Nelson Breakdown of academic impact, for papers by Johannes Heemskerk Breakdown of academic impact, for papers by Nhat Le Breakdown of academic impact, for papers by Conrad Chan Breakdown of academic impact, for papers by Desirée L. Bos Breakdown of academic impact, for papers by Janik Puttemans
Rankless by CCL
2026